financetom
Market
financetom
/
Market
/
Japan's Nikkei ticks higher before earnings finale, US CPI
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Japan's Nikkei ticks higher before earnings finale, US CPI
May 13, 2024 11:51 PM

(Updates with closing prices)

By Kevin Buckland

TOKYO, May 14 (Reuters) - Japan's Nikkei share average

ticked higher on Tuesday in largely directionless trade, as

investors braced for the finale of the local earnings season and

the release of closely watched U.S. inflation figures the

following day.

The Nikkei finished the day up 0.46% at 38,356.06,

with 125 of its 225 components rising versus 100 that fell,

following a relatively calm session. The broader Topix

rose 0.25%.

Earnings produced some stand-out winners and losers,

including heavyweight startup investor SoftBank Group,

which rallied 4.34% to make it the Nikkei's biggest support.

Furukawa Electric ( FUWAF ) surged almost 19% to pace

advancers, while refiner ENEOS Holdings ( JXHGF ) jumped more

than 10% after reporting results during the afternoon session.

At the other end, construction company Kajima ( KAJMF ) and

chemical company Tosoh Corp ( TOSCF ) were the two leading

decliners, each sliding close to 9%.

Some 600 companies report over the course of Tuesday, and

about the same number report Wednesday, when the current

earnings season largely comes to a close.

"There are a lot of individual drivers, but unfortunately

none that give an overall direction to the market," Kazuo

Kamitani, an equities strategist at Nomura Securities said.

Without additional catalysts, the Nikkei will fluctuate

narrowly between the five- and 25-day moving averages at around

38,170 and 38,450 respectively, Kamitani projected.

Daiwa Securities ( DSECF ) was another notable loser on

Tuesday, dropping 6.82% on news that it would invest 51.9

billion yen ($331.78 million) in Aozora Bank ( AOZOF ), making it

the biggest shareholder. Aozora Bank ( AOZOF ) shares eased 0.91%.

Drugmaker Shionogi fell more than 4% after saying

its COVID treatment pill failed in a trial to show a

statistically significant reduction in symptoms.

Peer Chugai Pharmaceutical ( CHGCF ) lost 3.38% following a

successful trial of a rival haemophilia treatment from Novo

Nordisk.

($1 = 156.4300 yen)

(Reporting by Kevin Buckland; Editing by Subhranshu Sahu and

Mrigank Dhaniwala)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US STOCKS-Wall Street listless in countdown to Nvidia results, Fed minutes
US STOCKS-Wall Street listless in countdown to Nvidia results, Fed minutes
May 22, 2024
(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window.) * Nvidia ( NVDA ) shares fall ahead of results, due after market close * Minutes of Fed meeting expected at 2 pm ET * Target's ( TGT ) weak results weigh on shares * TJX lifts annual profit...
Wall Street moves in a tight range of trading
Wall Street moves in a tight range of trading
May 22, 2024
US stock indices were mixed on Wednesday but still moved within a tight range of trading ahead of the release of Feds minutes. Later today, the Federal Reserve will release its minutes of its last meeting, which could include clues on the future of monetary policy. Fed Chair Jerome Powell said last week that he expects US inflation to slow...
Top Midday Stories: US Targets August 1 Start Date for China Tariff Hikes; CFPB Says BNPL Requires Credit Card-Level Oversight; Target Shares Fall on Earnings Miss; Third BHP Bid Rejected by Anglo Ame
Top Midday Stories: US Targets August 1 Start Date for China Tariff Hikes; CFPB Says BNPL Requires Credit Card-Level Oversight; Target Shares Fall on Earnings Miss; Third BHP Bid Rejected by Anglo Ame
May 22, 2024
12:24 PM EDT, 05/22/2024 (MT Newswires) -- The major US indexes were mixed on Wednesday morning, as investors eagerly awaited Nvidia's ( NVDA ) earnings report as well as the minutes from the most recent Federal Open Market Committee meeting. In policy news, the US Trade Representative proposed that tariff hikes on certain Chinese products, including electric vehicles and their...
Zai Lab Doses First Patient in a Phase 2 Clinical Trial of Plaque Psoriasis Treatment; Shares Rise
Zai Lab Doses First Patient in a Phase 2 Clinical Trial of Plaque Psoriasis Treatment; Shares Rise
May 22, 2024
10:50 AM EDT, 05/22/2024 (MT Newswires) -- Zai Lab ( ZLAB ) said Wednesday the first patient has been dosed in a phase 2 clinical trial of its ZL-1102 therapy to treat chronic plaque psoriasis, an inflammatory autoimmune skin disease. The primary endpoint is the proportion of patients achieving at least a 75% reduction in the modified Psoriasis Area Severity...
Copyright 2023-2025 - www.financetom.com All Rights Reserved